Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

. 2022 Jan ; 54 () : 90-99. [epub] 20210910

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/pmid34607722

Bipolar disorder (BD) might be associated with higher infection rates of coronavirus disease (COVID-19) which in turn could result in worsening the clinical course and outcome. This may be due to a high prevalence of somatic comorbidities and an increased risk of delays in and poorer treatment of somatic disease in patients with severe mental illness in general. Vaccination is the most important public health intervention to tackle the ongoing pandemic. We undertook a systematic review regarding the data on vaccinations in individuals with BD. Proportion of prevalence rates, efficacy and specific side effects of vaccinations and in individuals with BD were searched. Results show that only five studies have investigated vaccinations in individuals with BD, which substantially limits the interpretation of overall findings. Studies on antibody production after vaccinations in BD are very limited and results are inconsistent. Also, the evidence-based science on side effects of vaccinations in individuals with BD so far is poor.

BIOARABA Department of Neuroscience UPV EHU CIBERSAM Vitoria Spain

Charité Universitätsmedizin Berlin Department of Child and Adolescent Psychiatry Berlin Germany; Donald and Barbara Zucker School of Medicine at Hofstra Northwell Department of Psychiatry and Molecular Medicine Hempstead NY USA; The Zucker Hillside Hospital Department of Psychiatry Northwell Health Glen Oaks NY USA

Copenhagen Affective Disorder research Center Psychiatric Center Copenhagen Copenhagen Denmark; Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

Dalhousie University Department of Psychiatry Canada National Institute of Mental Health Klecany Czech Republic; National Institute of Mental Health Klecany Czech Republic

Departement of Psychiatry Service Hospitalo Universitaire GHU Paris Psychiatrie and Neurosciences Paris France Université de Paris Paris France

Department for Psychiatry Psychotherapy and Psychosomatic Vivantes Hospital am Urban and Friedrichshain; Charité Universitätsmedizin Berlin Germany

Department of Genetic Epidemiology in Psychiatry Central Institute of Mental Health University Heidelberg Medical Faculty Mannheim Mannheim Germany

Department of Psychiatry Aalborg University Hospital Aalborg Denmark; Department of Clinical Medicine Aalborg University Aalborg Denmark

Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology University of Gothenburg Gothenburg Sweden; Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

Department of Psychiatry and Psychotherapy Carl Gustav Carus University Hospital Dresden Technische Universität Dresden Dresden Germany

Department of Psychiatry Icahn School of Medicine at Mount Sinai New York USA; Department of Psychiatry Erasmus Medical Center Rotterdam the Netherlands

Department of Psychiatry Psychosomatic Medicine and Psychotherapy; University Hospital Frankfurt Frankfurt am Main Germany

Department of Psychiatry University of Oxford Oxford United Kingdom

Dept of Psychiatry Amsterdam University Medical Centers Vrije Universiteit Amsterdam Netherlands

Dokuz Eylul University Izmir Turkey Department of Psychiatry

Institute of Neuroscience Hospital Clinic University of Barcelona IDIBAPS CIBERSAM Barcelona Catalonia Spain

Institute of Neuroscience Newcastle University Newcastle UK

Laboratory of Pharmacogenomics Department of Biomedical Sciences University of Cagliari Cagliari Italy

LMU University Hospital Institute of Psychiatric Phenomics and Genomics Ludwig Maximilians University of Munich Germany

Medical University Graz Department of Psychiatry and Psychotherapeutic Medicine

Medical University Graz Klinische Abteilung für Rheumatologie und Immunologie

NORMENT Centre Division of Mental Health and Addiction Oslo University Hospital Oslo Norway

NORMENT Centre Division of Mental Health and Addiction Oslo University Hospital Oslo Norway; NORMENT Centre Institute of Clinical Medicine University of Oslo Oslo Norway

Osakidetza Basque Health Service Health Service BioAraba Research Institute University of the Basque Country Vitoria Spain; The Psychology Clinic of East Anglia Norwich England

St Olav University Hospital and Norwegian University of Science and Technology NTNU Faculty of Medicine and Health Sciences

Unit of Psychiatry Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy; Unit of Clinical Psychiatry University Hospital Agency of Cagliari Cagliari Italy; Department of Pharmacology Dalhousie University Halifax NS Canada

Universita di Siena Molecular Medicine

Universite de Paris INSERM UMRS 1144 DMU Neurosciences GHU Lariboisière Fernand Widal Departement de Psychiatrie APHP Paris France

Zobrazit více v PubMed

Anderson G., Berk M., Dean O., Moylan S., Maes M. Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications. CNS Drugs. 2014;28(1):1–10. PubMed

Arbelo N., López-Pelayo H., Sagué M., Madero S., Pinzón-Espinosa J., Gomes-da-Costa S., Ilzarbe L., Anmella G., Llach C.D., Imaz M.L., Cámara M.M., Pintor L. Psychiatric Clinical Profiles and Pharmacological Interactions in COVID-19 Inpatients Referred to a Consultation Liaison Psychiatry Unit: a Cross-Sectional Study. Psychiatr. Q. 2021:1–13. PubMed PMC

Barber S., Reed L., Syam N., Jones N., 2020. Severe mental illness and risks from COVID-19, Available from: https://www.cebm.net/covid-19/severe-mental-illness-and-risks-from-covid19/#:∼:text=People%20with%20severe%20mental%20illness,data%20that%20quantified%20these%20risks.

Batty, G.D., Deary, I.J., Altschul, D., 2021. Pre-pandemic mental and physical health as predictors of COVID-19 vaccine hesitancy: evidence from a UK-wide cohort study. medRxiv [Preprint]. 2021 Apr 30:2021.04.27.21256185. doi:10.1101/2021.04.27.21256185. PubMed DOI PMC

Bazargan M., Wisseh C., Adinkrah E., Ameli H., Santana D., Cobb S., Assari S. Influenza Vaccination among Underserved African-American Older Adults. Biomed. Res. Int. 2020;2020(2):1–9. PubMed PMC

Breton G., Mendoza P., Hägglöf T., Oliveira T.Y., Schaefer-Babajew D., Gaebler C., Turroja M., Hurley A., Caskey M., Nussenzweig M.C. Persistent cellular immunity to SARS-CoV-2 infection. J. Exp. Med. 2021;218(4) PubMed PMC

Brodziński S., Nasierowski T. Psychosis in Borrelia burgdorferi infection–part II. Psychiatr. Pol. 2019;53(3):641–653. PubMed

Buchwald D., Sheffield J., Furman R., Hartman S., Dudden M., Manson S. Influenza and pneumococcal vaccination among Native American elders in a primary care practice. Arch. Intern. Med. 2000;160(10):1443–1448. PubMed

Castro M.V., Gunning F.M., McCoy T.H., Perlis R.H. Mood Disorders and outcomes of COVID-19 hospitalizations. Am. J. Psychiatry. 2021 doi: 10.1176/appi.ajp.2020.20060842. appiajp202020060842. PubMed DOI

Cohen S., Williamson G.M. Stress and infectious disease in humans. Psychol. Bull. 1991;109(1):5. PubMed

Colomer L., Anmella G., Vieta E., Grande I. Physical health in affective disorders: a narrative review of the literature. Braz. J. Psychiatry. 2020 S1516-44462020005037202. PubMed PMC

Correll C.U., Solmi M., Veronese N., Bortolato B., Rosson S., Santonastaso P., Thapa-Chhetri N., Fornaro M., Gallicchio D., Collantoni E., Pigato G., Favaro A., Monaco F., Kohler C., Vancampfort D., Ward P.B., Gaughran F., Carvalho A.F., Stubbs B. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. PubMed PMC

Dalkner N., Reininghaus E., Schwalsberger K., Rieger A., Hamm C., Pilz R., Lenger M., Queissner R., Falzberger V.S., Platzer M., Fellendorf F.T., Birner A., Bengesser S.A., Weiss E.M., McIntyre R.S., Mangge H., Reininghaus B. C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders. Nutrients. 2020;12(10):3019. PubMed PMC

De Beaurepaire R., Fattal-German M., Kramartz P., Gékière F., Bizzini B., Rioux P., Borenstein P. Etude des réactions immunitaires humorales et cellulaires dans diverses formes de pathologies psychiatriques 22 chroniques [Humoral and cellular immunologic reactions in various forms of chronic psychiatric diseases] Encephale. 1994;20(1):57–64. PubMed

De Hert M., Correll C.U., Bobes J., Cetkovich-Bakmas M., Cohen D.A.N., Asai I., Detraux J., Gautam S., Möller H.J., Ndetei D.M., Newcomer J.W., Uwakwe R., Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World psychiatry. 2011;10(1):52. PubMed PMC

De Hert M., Dekker J.M., Wood D., Kahl K.G., Holt R.I.G., Möller H.J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) Eur. Psychiatry. 2009;24(6):412–424. PubMed

De Hert M., Mazereel V., Detraux J., Van Assche K. Prioritizing COVID-19 vaccination for people with severe mental illness. World Psychiatry. 2020;2021:1. PubMed PMC

De Picker L.J., Dias M.C., Benros M.E., Vai B., Branchi I., Benedetti F., Borsini A., Leza J.C., Kärkkäinen H., Männikkö M., Pariante C.M., Güngör E.S., Szczegielniak A., Tamouza R., van der Markt A., Fusar-Poli P., Beezhold J., Leboyer M. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021;8(5):356–359. PubMed PMC

De Serres G., Rouleau I., Skowronski D.M., Ouakki M., Lacroix K., Bédard F., Toth E., Landry M., Dupré N. Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: clinical features and risk factors. Vaccine. 2015;33(36):4464–4471. PubMed

Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord. 2013;150(2):456–459. PubMed

Ford B.N., Yolken R.H., Dickerson F.B., Teague T.K., Irwin M.R., Paulus M.P., Savitz J. Reduced immunity to measles in adults with major depressive disorder. Psychol. Med. 2019;49(2):243. PubMed PMC

Harris C., Barraclough B. Addressing mental health needs disorder. Br. J. Psychiatry. 1998;173(1):11–53. PubMed

Hayes J.F., Miles J., Walters K., King M., Osborn D.P.J. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr. Scand. 2015;131(6):417–425. PubMed PMC

Heggelund J., Vancampfort D., Tacchi M.J., Morken G., Scott J. Is there an association between cardiorespiratory fitness and stage of illness in psychotic disorders? A systematic review and meta-analysis. Acta Psychiatr. Scand. 2020;141(3):190–205. PubMed

Hernández-Gómez A., Andrade-González N., Lahera G., Vieta E. Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic. J. Affect. Disord. 2021;279:117–121. PubMed PMC

Kessing L.V., Ziersen S.C., Andersen P.K., Vinberg M.J.A. Nation-wide population-based longitudinal study mapping physical diseases in patients with bipolar disorder and their siblings. Affect Disord. 2021;282:18–25. PubMed

Kwon D.S., Kim K., Park S.M. Factors associated with influenza vaccination coverage among the elderly in South Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV) BMJ Open. 2016;6(12) e012618. 24. PubMed PMC

Lackner N., Mangge H., Reininghaus E.Z., McIntyre R.S., Bengesser S.A., Birner A., Reininghaus B., Kapfhammer H.P., Wallner-Liebmann S.J. Body fat distribution and associations with metabolic and clinical characteristics in bipolar individuals. Eur. Arch. Psychiatry Clin. Neurosci. 2015;265(4):313–319. PubMed

Landén M., Larsson H., Lichtenstein P., Westin J., Song J. Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder. Int. J. Bipolar Disord. 2021;9(1):4. PubMed PMC

Lavela S.L., Goldstein B., Etingen B., Miskevics S., Weaver F.M. Factors Associated With H1N1 influenza vaccine receipt in a high-risk population during the 2009-2010 H1N1 influenza pandemic. Top Spinal Cord. Inj. Rehabil. 2012;18(4):306–314. PubMed PMC

Lawrence T., Zubatsky M., Meyer D. The association between mental health diagnoses and influenza vaccine receipt among older primary care patients. Psychol. Health Med. 2020;25(9):1083–1093. PubMed

Lee S.W., Yang J.M., Moon S.Y., Yoo I.K., Ha E.K., Kim S.Y., Park U.M., Choi S., Lee S.-.H., Ahn Y.M., Kim J.M., Koh H.Y., Yon D.K. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7(12):1025–1031. PubMed PMC

Leslie D.L., Kobre R.A., Richmand B.J., Aktan Guloksuz S., Leckman J.F. Temporal. Association of certain neuropsychiatric disorders following vaccination of children and adolescents: a pilot case-control study. Front. Psychiatry. 2017;8:3. PubMed PMC

Maripuu M., Bendix M., Öhlund L., Widerström M., Werneke U. Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak-An Exploratory Cross-Sectional Analysis of a Population-Based Register Study. Front. Psychiatry. 2021;11 PubMed PMC

McIntyre R.S., Danilewitz M., Liauw S.S., Kemp D.E., Nguyen H.T., Kahn L.S., Kucyi A., Soczynska J.K., Woldeyohannes H.O., Lachowski A., Kim B., Nathanson J., Alsuwaidan M., Taylor V.H. Bipolar disorder and metabolic syndrome: an international perspective. J. Affect. Disord. 2010;126(3):366–387. PubMed

Miskovsky E., Gershman K., Clements M.L., Cupps T., Calandra G., Hesley T., Ioli V., Ellis R., Kniskern P., Miller W., Gerety R., West D. Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2+ S antigens. Vaccine. 1991;9(5):346–350. PubMed

Murali V., Oyebode F. Poverty, social inequality and mental health. Adv. Psychiatric Treatment. 2004;10(3):216–224.

Nielsen R.E., Banner J., Jensen S.E. Cardiovascular disease in patients with severe mental illness. Nat. Rev. Cardiol. 2021;18:136–145. PubMed

Patanavanich R., Glantz S.A. Smoking is associated with COVID-19 progression: a metaanalysis. Nicotine Tob. Res. 2020;22(9):1653–1656. PubMed PMC

Prather A.A., Pressman S.D., Miller G.E., Cohen S. Temporal Links Between Self-Reported Sleep and Antibody Responses to the Influenza Vaccine. Int. J. Behav. Med. 2021;28:151–158. PubMed

Queissner R., Pilz R., Dalkner N., Birner A., Bengesser S.A., Platzer M., Fellendorf F.T., Kainzbauer N., Herzog-Eberhard S., Hamm C., Reininghaus B., Zelzer S., Mangge H., Mansur R.B., McIntyre R.S., Kapfhammer H.P., Reininghaus E.Z. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder. Psychoneuroendocrinology. 2018;90:61–67. PubMed

Rødevand L., Steen N.E., Elvsåshagen T., Quintana D.S., Reponen E.J., Mørch R.H., Lunding S.H., Vedal T.S.J., Dieset I., Melle I., Lagerberg T.V., Andreassen O.A. Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade. Acta Psychiatr. Scand. 2019;139(4):348–360. PubMed

Russo R., Ciminale M., Ditommaso S., Siliquini R., Zotti C., Ruggenini A.M. Hepatitis B vaccination in psychiatric patients. Lancet North Am. Ed. 1994;343(8893):356. PubMed

Seminog O.O., Goldacre M.J. Risk of pneumonia and pneumococcal disease in people with severe mental illness: english record linkage studies. Thorax. 2013;68(2):171–176. PubMed

Shinn A.K., Viron M. Perspectives on the COVID-19 pandemic and individuals with serious mental illness. J Clin Psychiatry. 2020;81(3) 20com13412. PubMed

Soresina A., Moratto D., Chiarini M., Paolillo C., Baresi G., Focà E., Bezzi M., Baronio B., Giacomelli M., Badolato R. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr. Allergy Immunol. 2020;31(5):565–569. PubMed PMC

Stefana A., Youngstrom E.A., Chen J., Hinshaw S., Maxwell V., Michalak E., Vieta E. The COVID-19 pandemic is a crisis and opportunity for bipolar disorder. Bipolar Disord. 2020;22(6):641–643. PubMed PMC

Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–140. PubMed PMC

Vancampfort D., Correll C.U., Galling B., Probst M., De Hert M., Ward P.B., Rosenbaum S., Gaughran F., Lally J., Stubbs B. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–174. PubMed PMC

Vancampfort D., Stubbs B., Mitchell A.J., De Hert M., Wampers M., Ward P.B., Rosenbaum S., Correll C.U. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–347. PubMed PMC

Vardavas C.I., Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob. Induc. Dis. 2020;18:20. PubMed PMC

Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108(1):17–41. PubMed PMC

Wang Q., Xu R., Volkow N.D. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–130. PubMed PMC

Wasserman D., Iosue M., Wuestefeld A., Carli V. Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic. World Psychiatry. 2020;19(3):294–306. PubMed PMC

Yamagata A.S., Rizzo L.B., Cerqueira R.O., Scott J., Cordeiro Q., McIntyre R.S., Mansur R.B., Brietzke E. Differential impact of obesity on CD69 expression in individuals with bipolar disorder and healthy controls. Mol. Neuropsychiatry. 2018;3(4):192–196. PubMed PMC

Yao H., Chen J.H., Xu Y.F. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...